information pages about HIV and AIDS from ... new on aidsinfonyc ... Letter to HHS supports global funding Dr. Lee Jong-Wook, Director, WHO TAG Annual Report 2005 Donor Appeal Letter Spring 2006 TB/HIV Monitoring and Advocacy Grants TAGline, Volume 13, Issue 1, April 2006 ADAP coverage chart by state SCH 503034 trial excluded African-Americans BI and the Broken Social Contract CROI Report 2006 Antiretrovirals & Preclinical Pipelines updated Sign-on letter to WHO t ...

Welcome! Alliance Pharmaceutical Corp. is a research and development company focused on transforming innovative scientific discoveries into novel therapeutic and diagnostic agents. We are pleased that you have taken the time to visit our Home Page, and we hope that the following information will introduce you to our company. Please pardon our construction -- Our website is under revision. General Information Contact and Investor Information History of Alliance OxygentTM i ...

AMGENAbout AmgenScienceCorporate CitizenshipSitemapSearchPrivacy & TermsContact UsPatientsMedical ProfessionalsPartnersInvestorsCareersMediaLooking Within for the Answers to Cancer click here Jun 4 / Phase 2 Interim Data Show Denosumab Decreased Bone... Jun 3 / Interim Data Suggest Potential Benefits of Aranesp(R)... Jun 3 / New Interim Phase 2 Data Suggest the Antitumor Activity... Jun 3 / Interim Phase 2 Aranesp(R) Data Suggest Major Response... Featured LinksAmgen Tour of CaliforniaBreakaway From Cancer © 2000-2005 Amgen Inc. All Rights Reserved.

Patient Resources | Email Sign-up | Contact Us Helpful links to more information on diabetes, obesity and cardiovascular disease Press releases, news, SEC filings, presentation archives, stock information Amylin’s commitment to supporting the communities in which we work and live THERAPEUTIC FOCUSDiabetesObesityCardiovascular Amylin is dedicated to improving lives through the discovery, development and commercialization of innovative medicines for the t ...

The Anesthesia Medication Guide is available in PDA iSilo3 format. The Palm PDA version requires iSilo3 document reader from www.isilo.com Updated version available from "MemoWare"www.memoware.com Search for "Anesthesia" and navigate to the site Home Page

Soon ASM will provide Publish-Ahead-of-Print online PDF versions of manuscripts. Select an Issue from the Archive January 1972 - June 2006 Current Issue: June 2006 Search for Articles January 1972 - June 2006 ABOUT AAC INSTR. TO AUTHORS EDITORS SUBSCRIPTIONS ADVERTISING REPRINTS REVIEWER GUIDELINES MINIREVIEWS COPYRIGHT AND POSTING INFO SUBMIT MANUSCRIPTS REVIEWER PORTAL CDC SELECT AGENT INFO Other ASM Journals that may be of interest: Clin. Vaccine Immunol. ...

Antiviral Agents Bulletin The Antiviral Agents Bulletin ceased publication in March 2003. This site is archived (no longer updated). For 15 years (3/1988-3/2003), the Antiviral Agents Bulletin was the only periodical specializing in antiviral drug and vaccine development. The Bulletin covered all antiviral therapeutics, but the largest portion of news articles, patents, etc., concern HIV/AIDS-related antiviral drugs and vaccines. Articles in the Antiviral Agents Bulletin described an ...

Skip to content Home Media Investors Careers Products Licensing Research Responsibility About us Contact us Welcome to AstraZeneca's international website. As one of the world's leading pharmaceutical companies, our business is focused on turning good ideas into innovative, effective medicines that make a real difference in important areas of healthcare. Latest news 8 June 2006 : AstraZeneca Outlines Strategy to Further Strengthen Its Produ ...

Product WebsitesBetapaceAF®Betapace®Betaseron®Campath®Climara Pro™Climara®Feridex I.V.®Fludara®Leukine®Magnevist®Mirena®Refludan®Ultravist®Yasmin® SHR (NYSE): Last Trade: 108.34 (-0.46) | Updated: 6/9/2006 9:50:00 PM ET | Day High/Low: 109.13/108.25 Research & Development Products Investor Relations Careers Press Resources About Berlex Clinical Trials Is a specialty pharmaceutical company headquartered in New Jersey and the U.S. affiliate ...

June 7, 2006 - CTI to File for XYOTAX(TM) Marketing Approval in Europe on Equivalent Effectiveness (Non-Inferiority) and Superior Safety Using Existing STELLAR Clinical Trial Data June 5, 2006 - Data from CT-2106 Clinical Trial Presented at American Society of Clinical Oncology Meeting June 4, 2006 - Data from XYOTAX™ STELLAR Trials Presented at 2006 Meeting of American Society of Clinical Oncology June 1, 2006 - CTI and FDA Agree on NDA Filing Strate ...

This site has moved. You should be taken to the new site in approximately 10 seconds Copyright © 2002 Celltech Group Site last updated: 16th April 2002 Website Administrator

HomeSearchListingsResourcesHelpWhat's NewAbout ClinicalTrials.gov provides regularly updated information about federally and privately supported clinical research in human volunteers. ClinicalTrials.gov gives you information about a trial's purpose, who may participate, locations, and phone numbers for more details. The information provided on ClinicalTrials.gov should be used in conjunction with advice from health care professionals. Before searching, you may want to learn more about cli ...

Disease Index BRAIN BREAST CUTANEOUS Kaposi's Melanoma GASTROINTESTINAL Anus Colorectal Esophageal Gastric or Small Bowel Pancreas GENITOURINARY: Bladder Prostate Renal Testicular GYNECOLOGIC Endometrial Cervical Ovarian Head And Neck LEUKEMIAS-ADULT Acute Lymphocytic Chronic Lymphocytic Acute Myelogenous Chronic Myelogenous LUNG Non Small Cell Small Cell LYMPHOMA Hodgkin's Non Hodgkin's Multiple Myeloma SARCOMA Bony/Osteo Soft Tissue [ Top Of Page | DoseCalc Index ]

Prescription Drugs for Lung Diseases provides information on generic and brand name drugs available in Canada. How do particular drugs work in my body? Are there any unwanted or side effects? What precautions should I take? How do I take the medication? Prescription Drug Coverage in Canada. Your guide to reimbursement for prescription medications in Canada. Prescription drugs are approved by various governmental agencies federally and provincially. Access to Prescriptio ...

Home | Site map | Elsevier websites | Alerts Advanced Product Search Products Pharmacological Research Journal information Product description Editorial board Abstracting/indexing Special issues and supplements For Authors Guide for authors Online Submission Subscription information Bibliographic and ordering information Conditions of sale Dispatch dates Journal related information Imp ...

zaterdag 10 juni 2006 04:54 ZOEKEN Op deze siteOp internet HomeHelpSitemapLog inAbonneerMaak Elsevier mijn startpagina MODE Madonna tourt in H&M... Lees meer Nieuws Nederland Politiek Europese Unie Buitenland Economie Wetenschap Cultuur & Televisie Sport & Society Internet & Gadgets Laatste 24 uur Foto's van de week Nieuwsquiz Opinie Commentaren Leon de Winter Brussels Blog Simon Rozendaal Hugo Camps Columns Syp Wynia Essays Reacties Onderzoeken Schorsingen en verwijder ...

EUDERMA - VALPHARMA GROUP SPECIALISTS IN MODIFIED RELEASE CAPSULES AND TABLETS Click here for more information For any enquiry please contact us at the following addresses: Valpharma s.a.Euderma S.p.A. Via Ranco, 112 Via Rigardara 27-29 47031 Serravalle 47040 Cerasolo di Coriano Repubblica di San Marino Rimini (Italy) E-mail:valpharma@omniway.sm E-mail:euderma@infotel.it Tel:(From Italy) (From other countries)0549 900936 +378 900936 Tel:+39 (0)541 759264 Fax:(From Italy) (From other countries)0549 901409 +378 901409 Fax:+39 (0)541 756006 Telex:518521 euderm-i

Home Contact Us Site Index Search At ASCO 2006, data from over 200 abstracts in 20 types of cancer will be presented on Genentech's biooncology products. The ASCO Annual Meeting is the premier educational and scientific event for oncology professionals. Read the latest Genentech news releases. 78.51 -0.18 ...

We have detected that your browser does not have Javascript turned on. This site is optimized for Javascript. You may experience difficulties browsing certain parts of the site. Genzyme Corporate Home Genzyme Pharmaceuticals Home Search Contact Us Genzyme Websites Genzyme Pharmaceuticals is one of the first businesses acquired by Genzyme... more > Genzyme Pharmaceuticals and Brookwood Pharmaceuticals Enter Broad Collaboration in Drug Delivery with an Initia ...

Journal of Pharmacy & Pharmaceutical Sciences Editor, Fakhreddin Jamali A free and open access peer-reviewed online journal since 1998 — the first in the field Cited in major citation lists: Chemical Abstracts Current Contents Embase Index Medicus Library & Archives Canada PubMed Current Issue Archives Editorial Staff Associate Editors Editorial Board Author Instructions Manuscript Index CSPS Home Published by the Canadian Society for Pharmaceutical Sciences Copyright © 1997 CSPS 9th International Symposium on Pharmaceutical Sciences

Home | Careers | Site Map | Contact Us | Related Sites Home > Products For information on products formerly marketed by MylanBertek, select one of the following: Choose Product Amnesteem Avita Biobrane Biobrane-L Biobrane Gloves Clozapine Digitek Flexzan Granulex Hydrocol II Kristalose Maxzide Maxzide-25 Mentax Nitrek Phenytoin Phenytek Proderm Sorbsan Dressings Sulfamylon Solution Sulfamylon Cream Mylan Laboratories Product Guide Mylan Labor ...

Redistributed by University of Bonn, Medical Center NCI Cancer.gov Database Main Index Get this document via a secure connection Deutsch Search the Cancer.gov Files for Keywords (full-text retrieval) Test our new Search interface Search Interface (Using UMLS) . PDQ Statement List, which includes: PDQ Complete index PDQ Disease Topics for Physicians PDQ Disease Topics for Patients PDQ Supportive Care Topics for Physicians PDQ Supportive Care Topics for Patient ...

Pediatric Cardiology Pediatric Cardiothoracic Surgery Pediatrics Cardiovascular Disorders (Pediatrics) Children's Hospital Heart & Vascular Programs Pediatric Cardiovascular Services Program Description Rush Children’s Hospital provides complete clinical services for the diagnosis and treatment of congenital and acquired heart disease in children and young adults. We believe in the team approach, and often bring to ...

PROPHYLAXIS SURGICAL PROPHYLAXIS A single dose of a parenteral antibiotic given at induction or up to 30 minutes before induction usually provides adequate tissue concentrations for several hours. Antibiotic prophylaxis should therefore be given during this time period. Studies have shown that prophylaxis administered after commencement of surgery is of far less benefit. When surgery is prolonged or massive blood loss occurs, a second dose is advisable. Post operative doses of prophylacti ...

Questcor WELCOME TO QUESTCOR PHARMACEUTICALS, INC. Questcor is a specialty pharmaceutical company focused on providing prescription drugs for central nervous system (CNS) disorders. We are presently building a core portfolio of both marketed and development-stage products that address significant unmet medical needs. We will seek to develop and commercialize our own proprietary products, and are open to a range of partnering concepts in order to leverage our assets and build our portfolio. ...

Entire Site Articles/Fact Sheets Ask the Experts Conference Coverage TREATMENT TOPICS Treatment Basics Approved HIV Medications by Class Drug Interactions Medication Side Effects Drugs in Development This section is sponsored in part by: Twenty-five medications have been approved by the U.S. government to fight HIV, with many more in development. To learn when and how they are used, read up on the basics about HIV medications and use the list below. HIV medi ...

Entire Site Articles/Fact Sheets Ask the Experts Conference Coverage TREATMENT TOPICS Treatment Basics Approved HIV Medications by Class Drug Interactions Medication Side Effects Drugs in Development This section is sponsored in part by: Twenty-five medications have been approved by the U.S. government to fight HIV, with many more in development. To learn when and how they are used, read up on the basics about HIV medications and use the list below. HIV medi ...

Quick Links Director's Corner Updates from the Director Dictionary of Cancer Terms Cancer-related terms NCI Drug Dictionary Definitions, names, and links Funding Opportunities Research and training NCI Publications Order/download free booklets Advisory Boards and Groups Information, meetings, reports NIH Calendar of Events Scientific meetings Español Información en español NCI Highlights NCI Statement on FDA Approval of the ...

We are pleased to inform you that the Company name has been changed from Amrad Corporation Limited to Zenyth Therapeutics Limited effective from 1 December 2005. In a short while you will automatically be re-directed to our new web site. If your browser does not automatically re-direct click here. Zenyth Therapeutics Limited ABN 37 006 614 375 576 Swan Street Richmond Victoria Australia 3121 Telephone 61 3 9208 4000 Facsimile 61 3 9208 4350